MiniMed has officially separated from Medtronic, marking its first day as an independent company focused on advancing diabetes care. Medtronic exchanged its shares for MiniMed stock and no longer holds equity in MiniMed. This independence allows MiniMed to make autonomous decisions to enhance its insulin delivery systems and related therapies globally. The company aims to continue innovating and improving life for people with diabetes worldwide.
MiniMed Group Inc. (MMED) shares rose by 3.45% to USD 17.39 as of Oct 15, 2026 21:13 WIB, shortly after completing its separation from Medtronic. The company’s market cap stands at $4.73 billion with a trading volume of 67,620,827 on Pluang. Meanwhile, Medtronic (MDT) shares also gained 0.97% to USD 95.14, with a market cap of $120.53 billion and a dividend yield of 3.06%. This shift highlights investor interest in MiniMed’s new independent direction in diabetes care innovation.
